Climb Bio, Inc. (Nasdaq: CLYM), a clinical-stage biotechnology company developing therapeutics for immune-mediated diseases, today announced ...
We are thrilled to welcome Adam and Ashley to the Climb Bio leadership team,” said Aoife Brennan, M.B., Ch.B., President and Chief Executive Officer of Climb Bio. “Their addition comes at an important ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback